Jump to content
This site uses cookies. Continued use is acceptance of our Terms of Use and Privacy Policy. More Info... ×
  • Welcome to Celiac.com!

    You have found your celiac tribe! Join us and ask questions in our forum, share your story, and connect with others.




  • Celiac.com Sponsor (A1):



    Celiac.com Sponsor (A1-M):


  • Get Celiac.com Updates:
    Support Our Content
    eNewsletter
    Donate
  • Jefferson Adams
    Jefferson Adams

    Meet Dr. Robert Anderson: Leading the Charge in Celiac Disease Research

    Reviewed and edited by a celiac disease expert.

    Noted celiac disease researcher, Dr. Robert Anderson, joins the Celiac Disease Foundation.

    Meet Dr. Robert Anderson: Leading the Charge in Celiac Disease Research - Image: The State of Queensland (State Development and Infrastructure
    Caption: Image: The State of Queensland (State Development and Infrastructure

    03/01/2024 - In some exciting news for the celiac disease community, Dr. Robert Anderson, MB, ChB, PhD, a renowned figure in celiac disease research, has joined the Celiac Disease Foundation as its Principal Science & Innovation Advisor. With a prestigious background and a passion for advancing celiac disease research, Dr. Anderson's appointment marks a significant milestone for the Foundation and its mission to support individuals with celiac disease.

    Dr. Anderson's journey in celiac disease research began with his undergraduate studies in medicine and a PhD in New Zealand. He then pursued gastroenterology training in Melbourne, Australia, where he initiated his groundbreaking research on celiac disease. Dr. Anderson's work at Oxford University and the Walter and Eliza Hall Institute helped solidify the understanding of gluten-reactive T cells as the fundamental drivers of celiac disease.

    Celiac.com Sponsor (A12):
    One of Dr. Anderson's notable contributions to the field was his discovery of gluten-specific T cells circulating in the blood of individuals with celiac disease, highlighting the systemic nature of the condition. This groundbreaking research has paved the way for advancements in diagnostics and novel therapies for celiac disease.

    In his new role with the Celiac Disease Foundation, Dr. Anderson will leverage his expertise to identify key research priorities, manage research programs, and establish partnerships with researchers, clinicians, and industry leaders. His goal is to ensure that high-quality research is conducted to address the needs of the celiac disease community and advance our understanding of the condition.

    President of the International Society for the Study of Celiac Disease and the Co-Founder of Novoviah Pharmaceuticals

    Dr. Anderson's commitment to celiac disease research extends beyond his role at the Foundation. As the President of the International Society for the Study of Celiac Disease and the co-founder of Novoviah Pharmaceuticals, he continues to drive innovation and progress in the field.

    One of Dr. Anderson's upcoming engagements is the Asian-Pacific Celiac Disease Symposium in New Delhi, India, where he will participate in discussions on the challenges and opportunities for celiac disease in the Asian-Pacific region. As celiac disease becomes increasingly recognized in Asian countries, Dr. Anderson's expertise will be invaluable in addressing the infrastructure gaps in diagnosis, treatment, and management.

    The Celiac Disease Foundation is thrilled to welcome Dr. Robert Anderson to their team and looks forward to the impactful contributions he will make to advance celiac disease research and support individuals living with the condition. With Dr. Anderson's leadership and dedication, the future of celiac disease research is brighter than ever before.

    Read more at Celiac.org


    User Feedback

    Recommended Comments

    There are no comments to display.



    Create an account or sign in to comment

    You need to be a member in order to leave a comment

    Create an account

    Sign up for a new account in our community. It's easy!

    Register a new account

    Sign in

    Already have an account? Sign in here.

    Sign In Now

  • Get Celiac.com Updates:
    Support Celiac.com:
    Donate
  • About Me

    Jefferson Adams

    Jefferson Adams is Celiac.com's senior writer and Digital Content Director. He earned his B.A. and M.F.A. at Arizona State University. His articles, essays, poems, stories and book reviews have appeared in numerous magazines, journals, and websites, including North American Project, Antioch Review, Caliban, Mississippi Review, Slate, and more. He is the author of more than 2,500 articles on celiac disease. His university coursework includes studies in science, scientific methodology, biology, anatomy, physiology, medicine, logic, and advanced research. He previously devised health and medical content for Colgate, Dove, Pfizer, Sharecare, Walgreens, and more. Jefferson has spoken about celiac disease to the media, including an appearance on the KQED radio show Forum, and is the editor of numerous books, including "Cereal Killers" by Scott Adams and Ron Hoggan, Ed.D.

    >VIEW ALL ARTICLES BY JEFFERSON ADAMS

     


  • Celiac.com Sponsor (A17):
    Celiac.com Sponsor (A17):





    Celiac.com Sponsors (A17-M):




  • Related Articles

    Jefferson Adams
    Promising Celiac Disease
    Celiac.com 07/01/2019 - Drugmakers have pulled the plug on a phase II trial of Nexvax2, a promising drug for treating celiac disease. Pharmaceutical company ImmusanT, said that "results from an interim analysis revealed Nexvax2 did not provide statistically meaningful protection from gluten exposure for celiac disease patients when compared with placebo."
    That's a lot of fancy language to say that the drug simply didn't work. It did no better than a placebo. If there were any other way to spin it, the company would have spun it. They didn't. That basically means total failure.
    We've written about Nexvax2 over the years, and followed it through its development. It was promising enough to earn fast-track development status by the FDA.
    The company's press release reads...


    Scott Adams
    The Appeal of Vaccine Treatments for Celiac Disease
    Celiac.com 12/21/2020 - Recent leaps in understanding the development of celiac disease have led efforts toward a new, non-dietary, vaccine therapy. 
    A lifelong gluten-free diet remains the only treatment for celiac disease, but research shows that even the most diligent gluten-free dieters are likely to be exposed to gluten on a regular basis. This is part of the appeal of safe, effective non-dietary treatments for celiac disease. And adjunctive and/or vaccine therapy is one of those approaches.
    New therapies might focus on immune regulation by IL-10, as in vitro models of treated celiac patients show that external IL-10 can overwhelm the gliadin driven IFN-γ response in intestinal biopsies. But, even though people with active celiac disease show high levels of anti-infl...


    Jefferson Adams
    Nexvax2 Not Effective Against Acute Gluten-induced Symptoms
    Celiac.com 03/22/2023 - ImmusanT, the developers of Nexvax2, have stated that a gluten-free diet alone is not enough to treat celiac disease, as the gut can still be damaged and inflammatory reactions can still occur when gluten is consumed. Nexvax2 is an immunotherapy treatment that uses specific peptides to modify gluten-induced symptoms in celiac disease.
    A team of researchers recently set out to conduct a phase 2 trial, funded by ImmusanT, to investigate the effects of Nexvax2 on immune activation and gluten-induced symptoms in celiac disease patients. 
    The research team included Jason A Tye-Din, PhD; A James M Daveson, MBBS; Gautam Goel, PhD; Kaela E Goldstein, BS; Holly L Hand; Kristin M Neff, BS; Alina Popp, MD; Juha Taavela, MD; Prof Markku Maki, MD; Prof Jorma Isola,...


    Jefferson Adams
    Rise in Fatal Celiac-Related Cancer Alarms Researchers
    Celiac.com 02/19/2024 - A recent study presented at the 2023 annual meeting of the American College of Gastroenterology has raised concerns about the increasing incidence of enteropathy-associated T-cell lymphoma (EATL) – a rare and aggressive form of T-cell, non-Hodgkin lymphoma. This alarming trend has prompted researchers to explore the possible connection between EATL and celiac disease, shedding light on the risks faced by individuals with this autoimmune condition.
    Lead investigator Dr. Isabel Hujoel, Clinic Director of the Celiac Disease Center at UW Medical Center, Seattle, highlighted the strong association between EATL and celiac disease. While EATL is rare, most cases are observed in patients with celiac disease, suggesting a potential link between the two conditions. ...


  • Recent Activity

    1. - trents replied to nanny marley's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      8

      New here help needed

    2. - Mantooth replied to Mantooth's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      2

      Anyone Else Experiencing These Symptoms?

    3. - nanny marley replied to Mantooth's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      2

      Anyone Else Experiencing These Symptoms?

    4. - nanny marley replied to nanny marley's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      8

      New here help needed

    5. - nanny marley replied to nanny marley's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      8

      New here help needed


  • Celiac.com Sponsor (A19):



  • Member Statistics

    • Total Members
      126,552
    • Most Online (within 30 mins)
      7,748

    Limecandle
    Newest Member
    Limecandle
    Joined

  • Celiac.com Sponsor (A20):


  • Forum Statistics

    • Total Topics
      120.9k
    • Total Posts
      69.5k

  • Celiac.com Sponsor (A22):





  • Celiac.com Sponsor (A21):



  • Popular Now

    • nanny marley
      8
    • alimb
      5
    • Whyz
      6
    • Art Maltman
      6
    • JA917
      13
  • Popular Articles

    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
  • Upcoming Events

×
×
  • Create New...